Report error Found 9 Enz. Inhib. hit(s) with all data for entry = 12866
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 32nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 92nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 102nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 186nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 186nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 624nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 693nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 1.04E+3nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 1.14E+3nMAssay Description:The compounds were diluted in DMSO and configured into a solution with a final concentration of 10 mM; Dilute RIP1 kinase from 140 ng/μL to 20 ng/μL ...More data for this Ligand-Target Pair
